- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Orthopediatrics Corp(KIDS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for KIDS
11/20/2026: KIDS (2-star) has a low Upturn Star Rating. Not recommended to BUY.
OrthoPediatrics Corp. is a specialized healthcare equipment stock dedicated exclusively to designing orthopedic solutions for children. The company's primary business strength lies in its dominant niche positioning, high surgeon loyalty, and consistent double-digit revenue growth. Its investment story centers on capturing unaddressed pediatric procedures globally through innovative implants and consigned hospital instrument sets. Key risks include ongoing net unprofitability, small-cap market volatility, and execution risks tied to scaling commercial operations. The stock best suits growth-oriented investors willing to monitor path-to-profitability progress and procedural adoption trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | OrthoPediatrics offers robust double-digit top-line revenue expansion within a specialized, underpenetrated medical niche. |
| Momentum investor | Strong fit while signal remains positive | The stock attracts buying interest during periods of upward earnings revisions and expanding clinical adoption metrics. |
| Value investor | Weak fit | The company currently operates at a net loss and trades on growth expectations rather than near-term earnings or book value. |
| Dividend investor | Weak fit | OrthoPediatrics does not pay dividends, retaining all capital to fund commercial expansion and inventory deployment. |
| Low-risk investor | Weak fit | Small-cap volatility and lack of bottom-line profitability expose investors to higher equity risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | As a small-cap medtech stock, KIDS experiences sharper share price swings relative to large-cap healthcare benchmarks. |
| Valuation risk | Medium / high | Valuation relies heavily on sustained long-term revenue growth expectations rather than current earnings multiples. |
| Competition risk (large medtech conglomerates) | Medium | Well-capitalized orthopedic giants could potentially increase their focus on pediatric product subsets. |
| Business quality | Medium / high | The company maintains a high-integrity niche franchise with intense customer loyalty, though profitability remains a work in progress. |
| Dividend income | Low / none | Income-focused investors receive zero cash return from dividend distributions. |
| Execution risk | Medium / high | Successfully scaling international operations and hospital instrument set deployment is vital to achieving sustained profitability. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 828.75M USD | Price to earnings Ratio - | 1Y Target Price 33.88 |
Price to earnings Ratio - | 1Y Target Price 33.88 | ||
Volume (30-day avg) 358.5K shares | Beta 0.87 | 52 Weeks Range 14.42 - 34.53 | Updated Date 11/21/2026 |
52 Weeks Range 14.42 - 34.53 | Updated Date 11/21/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.42 |
Sector & Industry Intelligence
Sector
Healthcare
Constructive- Sentiment
- Strong Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 55.2%
- Active BUY / eligible
- 53 / 96
- 30-Day BUY Count Change
- +19
- Market state
- Strong Bullish
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Medical Devices
- BUY participation
- 33.3%
- Active BUY / eligible
- 2 / 6
- 30-Day BUY Count Change
- +2
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -18.32% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Surgical Implants and Instruments | Anatomically appropriate plate, screw, and rod systems used by pediatric orthopedic surgeons in operating rooms. | This is the core revenue engine, generating income each time specialized pediatric surgery kits are utilized. |
| Specialized Bracing | Custom and off-the-shelf pediatric braces, scoliosis management systems, and growth-modulation devices. | Provides a diversified revenue stream addressing non-operative and post-operative structural care. |
| Orthotic and Prosthetic Clinic Services | Direct clinic-based fitting, care, and treatment services for children. | Builds direct-to-patient service touchpoints and local recurring clinical revenue. |
| International and Export Markets | Direct sales operations and distributor networks across Europe, Latin America, Asia, and the Pacific. | Serves as an important secondary growth channel outside the domestic U.S. market. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 902.98M | Price to Sales(TTM) 3.14 |
Enterprise Value 902.98M | Price to Sales(TTM) 3.14 | ||
Enterprise Value to Revenue 3.42 | Enterprise Value to EBITDA 371.2 | Shares Outstanding 26.11M | Shares Floating 18.22M |
Shares Outstanding 26.11M | Shares Floating 18.22M | ||
Percent Insiders 29.69 | Percent Institutions 67.17 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

